SICHUAN KELUN-BIOTECH BIOPHARMACEUT earnings per share and revenue

6990 earnings per share for the last semiannual are 1.51 HKD whereas the estimation was -1.16 HKD which accounts for 230.59% surprise. Company revenue for the same period amounts to 1.49 B HKD despite the estimated figure of 919.26 M HKD. Estimated earnings per share for the next semiannual are -3.00 HKD, and revenue is expected to reach 630.65 M HKD. Also watch annual changes over time to get a bigger picture of 6990 earnings per share and revenue dynamics.